IMS Health Files for IPO


Applied Clinical Trials

IMS Health has filed a registration statement with the US Securities and Exchange Commission

IMS Health, which provides information, services and technology for the healthcare industry, that allows them to measure and improve performance, has filed a registration statement with the U.S. Securities and Exchange Commission for proposed initial public offering of its common stock.

In the clinical trials area, IMS Health acquired both DecisionView and TTC in 2012. DecisionView provided software solutions for patient enrollment in clinical trials, and TTC benchmarking and analytics solutions for negotiating costs of clinical trials through its GrantPlan database.

The full relase can be read here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.